Q32 Bio Balance Sheet Health
Financial Health criteria checks 5/6
Q32 Bio has a total shareholder equity of $48.8M and total debt of $17.6M, which brings its debt-to-equity ratio to 36%. Its total assets and total liabilities are $152.3M and $103.6M respectively.
Key information
36.0%
Debt to equity ratio
US$17.57m
Debt
| Interest coverage ratio | n/a |
| Cash | US$135.31m |
| Equity | US$48.77m |
| Total liabilities | US$103.57m |
| Total assets | US$152.33m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: QTTB's short term assets ($138.0M) exceed its short term liabilities ($33.0M).
Long Term Liabilities: QTTB's short term assets ($138.0M) exceed its long term liabilities ($70.6M).
Debt to Equity History and Analysis
Debt Level: QTTB has more cash than its total debt.
Reducing Debt: Insufficient data to determine if QTTB's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: QTTB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: QTTB has sufficient cash runway for 2.3 years if free cash flow continues to grow at historical rates of 40.3% each year.